CLA reduced abdominal adipose tissue in the metabolic syndrome – (09-02-01)



CLA reduced abdominal adipose tissue in the metabolic syndrome

Remember that CLA (conjugated linoleic acid) has a PPAR-gamma ligand effect, much like the new hotshot diabetes drugs (without the potential hepatic toxicity…). This study strongly supports the idea the CLA is another tool for the management of insulin resistance.

International Journal of Obesity abstract

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Diabetes and Obesity Tips
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”